Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTR3BP7 is one of several pseudogenes of the ACTR3B gene[1][5][6]. Unlike ACTR3B, which encodes the actin-related protein 3B (ARP3-beta)—a component of the Arp2/3 complex that regulates actin polymerization and cell shape—the pseudogene ACTR3BP7 shares sequence similarity with functional ACTR3B but does not encode a functional protein. Pseudogenes like ACTR3BP7 are typically inactive, having no known biological functions, no documented disease associations, and no relevance as therapeutic targets, biomarkers, or safety concerns. For structured drug target information, refer to the canonical ACTR3B gene[1][2][5][6].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTR3B pseudogene 7 (ACTR3BP7).